As reported, a universa firm ureteral stent was implanted in a patient on (b)(6) 2020.On (b)(6) 2021, the patient felt unwell and returned to the hospital for examination.It was discovered that previously diagnosed hydronephrosis had been aggravated, and the stone was attached to the stent.The patient had not returned to the hospital for review during this period.The physician arranged for surgery, removed the stent after a laser lithotripsy, and exchanged it for a new device.There was no treatment required for the hydronephrosis, which spontaneously resolved following the stent exchange.The patient was known to be in "good condition.".
|
Blank fields on this form indicate the information is unknown, unavailable, or unchanged.Event summary as reported, a universa firm ureteral stent was implanted in a patient on (b)(6) 2020.On (b)(6) 2021, the patient felt unwell and returned to the hospital for examination.It was discovered that previously diagnosed hydronephrosis had been aggravated, and the stone was attached to the stent.The patient had not returned to the hospital for review during this period.The physician arranged for surgery, removed the stent after a laser lithotripsy, and exchanged it for a new device.There was no treatment required for the hydronephrosis, which spontaneously resolved following the stent exchange.The patient was known to be in "good condition." investigation - evaluation reviews of the complaint history, device history record, instructions for use, manufacturing instructions, and quality control procedures and a visual inspection of the device were conducted during the investigation.One universa firm ureteral stent set was returned for investigation.The stent was returned with heavy encrustation starting approximately 20 cm from the proximal end and extending through the distal pigtail.The distal tip was occluded with encrustation.The length of the stent measured 24.5 cm from coil to coil.A document-based investigation evaluation was performed.No related non-conformances were recorded, and there have been no other reported complaints for this lot number.The device history record review provides objective evidence that the device was manufactured to specification.There is no evidence of nonconforming devices from the complaint lot in house or in the field.No gaps were discovered during reviews of the device manufacturing instructions or quality control procedures.Cook has concluded that sufficient inspection activities are in place.The device is provided with instructions for use which state, ¿ureteral stents should be checked periodically for signs of encrustation and proper function.Periodic checks of the stent by cystoscopic and/or radiographic procedures are recommended at intervals deemed to be appropriate by the physician in consideration of the individual patient¿s condition and other patient specific factors.The stent is not intended as a permanent indwelling device which should not exceed twelve months.¿ the ifu also lists potential adverse effects of stent placement, including occlusion, encrustation, and potential loss of renal function.Based on the available information and a clinical assessment of the event, cook has concluded that this event was caused by a known inherent risk of the device.Cook will continue monitoring of similar complaints and has notified the appropriate personnel of this event.Per the quality engineering risk assessment, no further action is required.This report is required by the fda under 21 cfr part 803 and is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement contained herein is intended to be an admission that any cook device is defective or malfunctioned, that a death or serious injury occurred, nor that any cook device caused, contributed to, or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
|